Total Payments
$12,502
2024 Payments
$2,176
Companies
53
Transactions
489
Medicare Patients
2,180
Medicare Billing
$234,661
Payment Breakdown by Category
Food & Beverage$12,107 (96.8%)
Travel$268.88 (2.2%)
Education$126.95 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,107 | 484 | 96.8% |
| Travel and Lodging | $268.88 | 1 | 2.2% |
| Education | $126.95 | 4 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,567 | 130 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,351 | 79 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,229 | 12 | $0 (2024) |
| Ethicon Inc. | $634.97 | 7 | $0 (2017) |
| PFIZER INC. | $502.11 | 37 | $0 (2024) |
| Gilead Sciences, Inc. | $466.30 | 16 | $0 (2024) |
| Celgene Corporation | $450.18 | 19 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $382.67 | 14 | $0 (2018) |
| Covidien LP | $378.56 | 9 | $0 (2019) |
| GlaxoSmithKline, LLC. | $363.65 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,176 | 78 | AstraZeneca Pharmaceuticals LP ($485.40) |
| 2023 | $2,530 | 90 | AbbVie Inc. ($628.57) |
| 2022 | $1,569 | 78 | ABBVIE INC. ($493.90) |
| 2021 | $1,558 | 75 | AbbVie Inc. ($399.62) |
| 2020 | $238.93 | 15 | AbbVie Inc. ($88.07) |
| 2019 | $510.20 | 16 | Janssen Scientific Affairs, LLC ($228.18) |
| 2018 | $1,172 | 39 | Synergy Pharmaceuticals Inc ($257.67) |
| 2017 | $2,749 | 98 | Ethicon Inc. ($634.97) |
All Payment Transactions
489 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Gastroenterology | ||||||
| 12/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $112.89 | General |
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Gastroenterology | ||||||
| 11/22/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $32.85 | General |
| Category: LIVER DISEASE | ||||||
| 11/20/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Diabetes Care | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $115.65 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $116.43 | General |
| Category: Respiratory | ||||||
| 09/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: LIVER DISEASE | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Gastroenterology | ||||||
| 09/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.85 | General |
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $106.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Gastroenterology | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 447 | 747 | $203,703 | $56,189 |
| 2022 | 10 | 543 | 802 | $227,780 | $58,302 |
| 2021 | 10 | 658 | 932 | $243,885 | $69,583 |
| 2020 | 10 | 532 | 649 | $194,064 | $50,588 |
Total Patients
2,180
Total Services
3,130
Medicare Billing
$234,661
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 146 | 245 | $64,188 | $22,172 | 34.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 89 | 89 | $30,397 | $10,148 | 33.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 53 | 54 | $42,381 | $4,370 | 10.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 26 | 26 | $18,348 | $4,262 | 23.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 37 | 122 | $7,874 | $3,185 | 40.5% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 14 | 64 | $4,750 | $3,064 | 64.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 24 | 24 | $21,735 | $2,835 | 13.0% |
| 99427 | Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 68 | $3,779 | $2,510 | 66.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 26 | $4,796 | $1,688 | 35.2% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 11 | 18 | $2,949 | $1,162 | 39.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,507 | $792.18 | 31.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 169 | $44,276 | $15,903 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 90 | 90 | $30,739 | $9,863 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 122 | $22,505 | $7,435 | 33.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 61 | 242 | $15,619 | $6,441 | 41.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 36 | 36 | $33,329 | $4,463 | 13.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 23 | 23 | $16,248 | $3,792 | 23.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 50 | 50 | $39,533 | $3,600 | 9.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 14 | 14 | $13,911 | $2,882 | 20.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 34 | 34 | $7,748 | $2,481 | 32.0% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 15 | 22 | $3,872 | $1,442 | 37.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 104 | 104 | $32,428 | $12,580 | 38.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 107 | 137 | $31,873 | $12,428 | 39.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 142 | 169 | $28,236 | $10,917 | 38.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 64 | 262 | $16,741 | $6,769 | 40.4% |
About Dr. Basher Atiquzzaman, M.D
Dr. Basher Atiquzzaman, M.D is a Gastroenterology healthcare provider based in Kissimmee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033159819.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Basher Atiquzzaman, M.D has received a total of $12,502 in payments from pharmaceutical and medical device companies, with $2,176 received in 2024. These payments were reported across 489 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($12,107).
As a Medicare-enrolled provider, Atiquzzaman has provided services to 2,180 Medicare beneficiaries, totaling 3,130 services with total Medicare billing of $234,661. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Kissimmee, FL
- Active Since 06/08/2006
- Last Updated 11/06/2013
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033159819
Products in Payments
- TRULANCE (Drug) $1,175
- LINX Reflux Management System (Device) $812.64
- FARXIGA (Drug) $599.77
- ZEPOSIA (Drug) $555.52
- XELJANZ (Drug) $486.50
- BREZTRI (Drug) $396.85
- Trulance (Drug) $382.67
- RINVOQ (Biological) $365.48
- LINZESS (Drug) $347.22
- STELARA (Biological) $339.39
- ZENPEP (Drug) $329.87
- Humira (Biological) $322.85
- CREON (Drug) $321.69
- DUPIXENT (Biological) $300.69
- SKYRIZI (Biological) $297.35
- XIFAXAN (Drug) $275.25
- MAVYRET (Drug) $274.09
- Axonics (Device) $273.48
- AIRSUPRA (Drug) $232.08
- Barrx (Device) $212.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Kissimmee
Muhammad Mohiuddin, M.d, M.D
Gastroenterology — Payments: $31,603
Gastroenterology $31,603
Celia Quinnonez, Md, MD
Gastroenterology — Payments: $8,430
Gastroenterology $8,430
Jaime Rivera, M.d, M.D
Gastroenterology — Payments: $3,716
Gastroenterology $3,716
Abdul Bhutta, Md, MD
Gastroenterology — Payments: $2,840
Gastroenterology $2,840
Dr. Seela Ramesh, M.d, M.D
Gastroenterology — Payments: $2,414
Gastroenterology $2,414
Dr. Charles Bisogno, D.o, D.O
Gastroenterology — Payments: $1,505
Gastroenterology $1,505